Genetic deletion of microsomal prostaglandin e synthase-1 suppresses mouse mammary tumor growth and angiogenesis

Prostaglandins and Other Lipid Mediators

Volumn 106, Issue , 2013, Pages 99-105

  Howe, Louise R ^a   Subbaramaiah, Kotha ^a   Kent, Claire V ^a   Zhou, Xi K ^a   Chang, Sung Hee ^a   Hla, Timothy ^a   Jakobsson, Per Johan ^b   Hudis, Clifford A ^c   Dannenberg, Andrew J ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Angiogenesis; Aromatase; Breast cancer; Mouse; mPGES 1; PGE2

Indexed keywords

AROMATASE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; PROSTAGLANDIN E SYNTHASE 1; PROSTAGLANDIN E2;

ANGIOGENESIS; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER GROWTH; CANCER INHIBITION; CANCER SIZE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENE; GENE DELETION; GENE LOSS; GENE OVEREXPRESSION; GROWTH INHIBITION; KNOCKOUT GENE; MOUSE; NONHUMAN; PROSTAGLANDIN E SYNTHASE 1 GENE; REDUCTION;

ANGIOGENESIS; AROMATASE; BREAST CANCER; MOUSE; MPGES-1; PGE(2);

ANIMALS; AROMATASE; CARCINOGENESIS; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; GENE DELETION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTRAMOLECULAR OXIDOREDUCTASES; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, TRANSGENIC; MICROVESSELS; NEOVASCULARIZATION, PATHOLOGIC; RECEPTOR, ERBB-2; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84888864864     PISSN: 10988823     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prostaglandins.2013.04.002     Document Type: Article

References (71)

1. J.R. Brown, and R.N. DuBois COX-2: a molecular target for colorectal cancer prevention J Clin Oncol 23 2005 2840 2855 (Pubitemid 46179475)
2. L.R. Howe Inflammation and breast cancer Cyclooxygenase/prostaglandin signaling and breast cancer Breast Cancer Res 9 2007 210
3. R.E. Harris, G.A. Alshafie, H. Abou-Issa, and K. Seibert Chemoprevention of breast cancer in rats by celecoxib, a cyclooxygenase 2 inhibitor Cancer Res 60 2000 2101 2103 (Pubitemid 30225166)
4. L.R. Howe, S.H. Chang, and K.C. Tolle HER2/neu-induced mammary tumorigenesis and angiogenesis are reduced in cyclooxygenase-2 knockout mice Cancer Res 65 2005 10113 10119 (Pubitemid 41541494)
5. C.H. Liu, S.H. Chang, and K. Narko Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice J Biol Chem 276 2001 18563 18569
6. G. Steinbach, P.M. Lynch, and R.K. Phillips The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis N Engl J Med 342 2000 1946 1952 (Pubitemid 30419089)
7. M.M. Bertagnolli, C.J. Eagle, and A.G. Zauber Celecoxib for the prevention of sporadic colorectal adenomas N Engl J Med 355 2006 873 884 (Pubitemid 44315980)
8. N. Arber, C.J. Eagle, and J. Spicak Celecoxib for the prevention of colorectal adenomatous polyps N Engl J Med 355 2006 885 895 (Pubitemid 44315981)
9. J.A. Baron, R.S. Sandler, and R.S. Bresalier A randomized trial of rofecoxib for the chemoprevention of colorectal adenomas Gastroenterology 131 2006 1674 1682 (Pubitemid 44958508)
10. S.D. Solomon, M.A. Pfeffer, and J.J. McMurray Effect of celecoxib on cardiovascular events and blood pressure in two trials for the prevention of colorectal adenomas Circulation 114 2006 1028 1035 (Pubitemid 44358879)
11. R.S. Bresalier, R.S. Sandler, and H. Quan Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial N Engl J Med 352 2005 1092 1102 (Pubitemid 40365350)
12. A. Rostom, C. Dube, and G. Lewin Nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors for primary prevention of colorectal cancer: a systematic review prepared for the U S. preventive services task force Ann Intern Med 146 2007 376 389 (Pubitemid 351650598)
13. C.D. Funk, and G.A. FitzGerald COX-2 inhibitors and cardiovascular risk J Cardiovasc Pharmacol 50 2007 470 479 (Pubitemid 350146448)
14. Y. Cheng, M. Wang, Y. Yu, J. Lawson, C.D. Funk, and G.A. Fitzgerald Cyclooxygenases, microsomal prostaglandin E synthase-1, and cardiovascular function J Clin Invest 116 2006 1391 1399
15. J.K. Hennan, J. Huang, and T.D. Barrett Effects of selective cyclooxygenase-2 inhibition on vascular responses and thrombosis in canine coronary arteries Circulation 104 2001 820 825 (Pubitemid 32762682)
16. T. Murata, F. Ushikubi, and T. Matsuoka Altered pain perception and inflammatory response in mice lacking prostacyclin receptor Nature 388 1997 678 682 (Pubitemid 27366439)
17. F. Seta, A.D. Chung, P.V. Turner, J.D. Mewburn, Y. Yu, and C.D. Funk Renal and cardiovascular characterization of COX-2 knockdown mice Am J Physiol Regul Integr Comp Physiol 296 2009 R1751 R1760
18. I. Kudo, and M.M. Prostaglandin E synthase, a terminal enzyme for prostaglandin E2 biosynthesis J Biochem Mol Biol 38 2005 633 638 (Pubitemid 43240966)
19. W.L. Smith, Y. Urade, and P.J. Jakobsson Enzymes of the cyclooxygenase pathways of prostanoid biosynthesis Chem Rev 111 2011 5821 5865
20. L.A. Jania, S. Chandrasekharan, and M.G. Backlund Microsomal prostaglandin E synthase-2 is not essential for in vivo prostaglandin E2 biosynthesis Prostaglandins Other Lipid Mediat 88 2009 73 81
21. A.K. Lovgren, and M. Kovarova Koller BH. cPGES/p23 is required for glucocorticoid receptor function and embryonic growth but not prostaglandin E2 synthesis Mol Cell Biol 27 2007 4416 4430 (Pubitemid 46906565)
22. L. Boulet, M. Ouellet, and K.P. Bateman Deletion of microsomal prostaglandin E2 (PGE2) synthase-1 reduces inducible and basal PGE2 production and alters the gastric prostanoid profile J Biol Chem 279 2004 23229 23237 (Pubitemid 38685630)
23. C.E. Trebino, J.L. Stock, and C.P. Gibbons Impaired inflammatory and pain responses in mice lacking an inducible prostaglandin E synthase Proc Natl Acad Sci USA 100 2003 9044 9049 (Pubitemid 36899220)
24. S. Uematsu, M. Matsumoto, K. Takeda, and S. Akira Lipopolysaccharide- dependent prostaglandin E(2) production is regulated by the glutathione- dependent prostaglandin E(2) synthase gene induced by the Toll-like receptor 4/MyD88/NF-IL6 pathway J Immunol 168 2002 5811 5816 (Pubitemid 34556168)
25. P.J. Jakobsson, S. Thoren, R. Morgenstern, and B. Samuelsson Identification of human prostaglandin E synthase: a microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target Proc Natl Acad Sci USA 96 1999 7220 7225 (Pubitemid 29299642)
26. B. Samuelsson, R. Morgenstern, and P.J. Jakobsson Membrane prostaglandin E synthase-1: a novel therapeutic target Pharmacol Rev 59 2007 207 224 (Pubitemid 47481434)
27. K. Yoshimatsu, N.K. Altorki, and D. Golijanin Inducible prostaglandin E synthase is overexpressed in non-small cell lung cancer Clin Cancer Res 7 2001 2669 2674 (Pubitemid 32911370)
28. K. Yoshimatsu, D. Golijanin, and P.B. Paty Inducible microsomal prostaglandin E synthase is overexpressed in colorectal adenomas and cancer Clin Cancer Res 7 2001 3971 3976 (Pubitemid 34044615)
29. E.G. Cohen, T. Almahmeed, and B. Du Microsomal prostaglandin E synthase-1 is overexpressed in head and neck squamous cell carcinoma Clin Cancer Res 9 2003 3425 3430 (Pubitemid 37082739)
30. B.P. van Rees, A. Sivula, and S. Thoren Expression of microsomal prostaglandin E synthase-1 in intestinal type gastric adenocarcinoma and in gastric cancer cell lines Int J Cancer 107 2003 551 556 (Pubitemid 37296114)
31. S. Mehrotra, A. Morimiya, B. Agarwal, R. Konger, and S. Badve Microsomal prostaglandin E2 synthase-1 in breast cancer: a potential target for therapy J Pathol 208 2006 356 363 (Pubitemid 43210522)
32. M. Nakanishi, V. Gokhale, E.J. Meuillet, and D.W. Rosenberg mPGES-1 as a target for cancer suppression: a comprehensive invited review "Phospholipase A2 and lipid mediators" Biochimie 92 2010 660 664
33. D. Kamei, M. Murakami, Y. Nakatani, Y. Ishikawa, T. Ishii, and I. Kudo Potential role of microsomal prostaglandin E synthase-1 in tumorigenesis J Biol Chem 278 2003 19396 19405 (Pubitemid 36799335)
34. H. Oshima, M. Oshima, K. Inaba, and M.M. Taketo Hyperplastic gastric tumors induced by activated macrophages in COX-2/mPGES-1 transgenic mice EMBO J 23 2004 1669 1678 (Pubitemid 38579527)
35. M. Nakanishi, D.C. Montrose, and P. Clark Genetic deletion of mPGES-1 suppresses intestinal tumorigenesis Cancer Res 68 2008 3251 3259
36. H. Hanaka, S.C. Pawelzik, and J.I. Johnsen Microsomal prostaglandin E synthase 1 determines tumor growth in vivo of prostate and lung cancer cells Proc Natl Acad Sci USA 106 2009 18757 18762
37. M. Nakanishi, A. Menoret, and T. Tanaka Selective PGE(2) suppression inhibits colon carcinogenesis and modifies local mucosal immunity Cancer Prev Res (Phila) 4 2011 1198 1208
38. D. Kamei, M. Murakami, and Y. Sasaki Microsomal prostaglandin E synthase-1 in both cancer cells and hosts contributes to tumour growth, invasion and metastasis Biochem J 425 2010 361 371
39. Y. Sasaki, D. Kamei, and Y. Ishikawa Microsomal prostaglandin E synthase-1 is involved in multiple steps of colon carcinogenesis Oncogene 31 2012 2943 2952
40. P.M. Siegel, E.D. Ryan, R.D. Cardiff, and W.J. Muller Elevated expression of activated forms of Neu/ErbB-2 and ErbB-3 are involved in the induction of mammary tumors in transgenic mice: implications for human breast cancer EMBO J 18 1999 2149 2164 (Pubitemid 29179172)
41. K. Subbaramaiah, P.G. Morris, and X.K. Zhou Increased levels of COX-2 and prostaglandin E2 contribute to elevated aromatase expression in inflamed breast tissue of obese women Cancer Discov 2 2012 356 365
42. K. Subbaramaiah, L.R. Howe, and P. Bhardwaj Obesity is associated with inflammation and elevated aromatase expression in the mouse mammary gland Cancer Prev Res (Phila) 4 2011 329 346
43. S. Chandrasekharan, N.A. Foley, L. Jania, P. Clark, L.P. Audoly, and B.H. Koller Coupling of COX-1 to mPGES1 for prostaglandin E2 biosynthesis in the murine mammary gland J Lipid Res 46 2005 2636 2648 (Pubitemid 43107475)
44. S. Gately, and W.W. Li Multiple roles of COX-2 in tumor angiogenesis: a target for antiangiogenic therapy Semin Oncol 31 2004 2 11 (Pubitemid 38879409)
45. K.M. Leahy, A.T. Koki, and J.L. Masferrer Role of cyclooxygenases in angiogenesis Curr Med Chem 7 2000 1163 1170
46. S.H. Chang, C.H. Liu, and R. Conway Role of prostaglandin E2-dependent angiogenic switch in cyclooxygenase 2-induced breast cancer progression Proc Natl Acad Sci USA 101 2004 591 596 (Pubitemid 38084681)
47. E.S. Diaz-Cruz, and R.W. Brueggemeier Interrelationships between cyclooxygenases and aromatase: unraveling the relevance of cyclooxygenase inhibitors in breast cancer Anticancer Agents Med Chem 6 2006 221 232 (Pubitemid 43796640)
48. V.R. Agarwal, S.E. Bulun, M. Leitch, R. Rohrich, and E.R. Simpson Use of alternative promoters to express the aromatase cytochrome P450 (CYP19) gene in breast adipose tissues of cancer-free and breast cancer patients J Clin Endocrinol Metab 81 1996 3843 3849 (Pubitemid 26380384)
49. S. Chen, D. Zhou, T. Okubo, Y.C. Kao, and C. Yang Breast tumor aromatase: functional role and transcriptional regulation Endocr Relat Cancer 6 1999 149 156 (Pubitemid 29260046)
50. E.S. Diaz-Cruz, C.L. Shapiro, and R.W. Brueggemeier Cyclooxygenase inhibitors suppress aromatase expression and activity in breast cancer cells J Clin Endocrinol Metab 90 2005 2563 2570 (Pubitemid 40686292)
51. J.R. Prosperi, and F.M. Robertson Cyclooxygenase-2 directly regulates gene expression of P450 Cyp19 aromatase promoter regions pII, pI.3 and pI 7 and estradiol production in human breast tumor cells Prostaglandins Other Lipid Mediat 81 2006 55 70 (Pubitemid 44403171)
52. K. Subbaramaiah, L.R. Howe, and E.R. Port HER-2/neu status is a determinant of mammary aromatase activity in vivo: evidence for a cyclooxygenase-2-dependent mechanism Cancer Res 66 2006 5504 5511 (Pubitemid 43844979)
53. 2 via cyclic AMP, leading to activation of promoter II of the CYP19 (aromatase) gene Endocrinology 137 1996 5739 5742 (Pubitemid 26423150)
54. A.M. Brodie, Q. Lu, and B.J. Long Aromatase and COX-2 expression in human breast cancers J Steroid Biochem Mol Biol 79 2001 41 47 (Pubitemid 34158777)
55. R.W. Brueggemeier, A.L. Quinn, M.L. Parrett, F.S. Joarder, R.E. Harris, and F.M. Robertson Correlation of aromatase and cyclooxygenase gene expression in human breast cancer specimens Cancer Lett 140 1999 27 35 (Pubitemid 29251310)
56. P.G. Morris, C.A. Hudis, and D. Giri Inflammation and increased aromatase expression occur in the breast tissue of obese women with breast cancer Cancer Prev Res (Phila) 4 2011 1021 1029
57. N. Elander, J. Ungerback, H. Olsson, S. Uematsu, S. Akira, and P. Soderkvist Genetic deletion of mPGES-1 accelerates intestinal tumorigenesis in APC(Min/+) mice Biochem Biophys Res Commun 372 2008 249 253
58. H. Kamata, K. Hosono, and T. Suzuki mPGES-1-expressing bone marrow-derived cells enhance tumor growth and angiogenesis in mice Biomed Pharmacother 64 2010 409 416
59. F. Finetti, E. Terzuoli, and E. Bocci Pharmacological inhibition of microsomal prostaglandin E synthase-1 suppresses epidermal growth factor receptor-mediated tumor growth and angiogenesis PLoS ONE 7 2012 e40576
60. B.H. von Rahden, B.L. Brucher, C. Langner, J.R. Siewert, H.J. Stein, and M. Sarbia Expression of cyclo-oxygenase 1 and 2, prostaglandin E synthase and transforming growth factor beta1, and their relationship with vascular endothelial growth factors A and C, in primary adenocarcinoma of the small intestine Br J Surg 93 2006 1424 1432 (Pubitemid 44736095)
61. K. Liby, M. Rendi, and N. Suh The combination of the rexinoid, LG100268, and a selective estrogen receptor modulator, either arzoxifene or acolbifene, synergizes in the prevention and treatment of mammary tumors in an estrogen receptor-negative model of breast cancer Clin Cancer Res 12 2006 5902 5909 (Pubitemid 44629624)
62. P.B. Gupta, D. Proia, and O. Cingoz Systemic stromal effects of estrogen promote the growth of estrogen receptor-negative cancers Cancer Res 67 2007 2062 2071 (Pubitemid 46424224)
63. V. Iyer, I. Klebba, and J. McCready Estrogen promotes ER-negative tumor growth and angiogenesis through mobilization of bone marrow-derived monocytes Cancer Res 72 2012 2705 2713
64. C. Pequeux, I. Raymond-Letron, and S. Blacher Stromal estrogen receptor-alpha promotes tumor growth by normalizing an increased angiogenesis Cancer Res 72 2012 3010 3019
65. D.W. Losordo, and J.M. Isner Estrogen and angiogenesis: a review Arterioscler Thromb Vasc Biol 21 2001 6 12 (Pubitemid 32061922)
66. H.H. Chang, and E.J. Meuillet Identification and development of mPGES-1 inhibitors: where we are at? Future Med Chem 3 2011 1909 1934
67. A. Bruno, L. Di Francesco, and I. Coletta Effects of AF3442 [N-(9-ethyl-9H-carbazol-3-yl)-2-(trifluoromethyl)benzamide], a novel inhibitor of human microsomal prostaglandin E synthase-1, on prostanoid biosynthesis in human monocytes in vitro Biochem Pharmacol 79 2010 974 981
68. A. Koeberle, A. Rossi, and H. Zettl The molecular pharmacology and in vivo activity of 2-(4-chloro-6-(2,3-dimethylphenylamino)pyrimidin-2-ylthio) octanoic acid (YS121), a dual inhibitor of microsomal prostaglandin E2 synthase-1 and 5-lipoxygenase J Pharmacol Exp Ther 332 2010 840 848
69. G. Mbalaviele, A.M. Pauley, and A.F. Shaffer Distinction of microsomal prostaglandin E synthase-1 (mPGES-1) inhibition from cyclooxygenase-2 inhibition in cells using a novel, selective mPGES-1 inhibitor Biochem Pharmacol 79 2010 1445 1454
70. F. Rorsch, E. Buscato, and K. Deckmann Structure-activity relationship of nonacidic quinazolinone inhibitors of human microsomal prostaglandin synthase 1 (mPGES 1) J Med Chem 55 2012 3792 3803
71. D. Xu, S.E. Rowland, and P. Clark MF63 [2-(6-chloro-1H-phenanthro[9,10-d] imidazol-2-yl)-isophthalonitrile], a selective microsomal prostaglandin E synthase-1 inhibitor, relieves pyresis and pain in preclinical models of inflammation J Pharmacol Exp Ther 326 2008 754 763